Obalon Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St indexes climb after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Obalon Therapeutics (OBLN) IPO Opens Modestly Higher
October 6, 2016 11:00 AM EDTToday's IPO for Obalon Therapeutics, Inc. (Nasdaq: OBLN) opened for trading at $15.21 after pricing 5,000,000 shares of its common stock at a price to the public of $15 per share, the middle of the expected $14-$16 range.
UBS Investment Bank, Canaccord Genuity and Stifel are acting as joint book-running managers for the offering. BTIG is... More
